Chart of Day: Buy this Pharma Stock on the Pullback

You are receiving this email because you are subscribed to Daily Guru Trades. If you no longer wish to receive these emails, please unsubscribe here. Eli Lilly (SYM: LLY) is offering opportunity on its recent pullback to $935 a share. After catching support at just under $895, it's starting to pivot higher again. From here, we'd like to see LLY initially retest $960.  Helping, sales of its diabetes and obesity medications, Mounjaro and Zepbound are still strong. Two, LLY yields 0.57% at the moment. While it's not a substantial dividend, it's still an added bonus for a stock set to explode even higher. In its most recent earnings report, company revenue jumped 36% thanks to those two obesity treatment stocks. Second quarter EPS of $3.28 was up 68% year over year. Plus, the company even raised its full-year guidance by $3 billion. It also raised its EPS guidance to a new range of $15.10 to $15.60 and non-GAAP EPS to a new range of $16.10 to $16.60. Even better, analysts at Citi just resumed coverage of LLY with a $1,060 price target. The firm says increased Zepbound forecasts could send the stock to higher highs. "We believe the market currently underestimates the potential for key diabetes and obesity drugs Mounjaro and Zepbound (tirzepatide) and the diabetes/obesity pipeline (retatrutide and orforglipron), as well as other assets including Omvoh in UC and Crohn's, and Verzenio in adjuvant breast and prostate cancer," they added, as quoted by CNBC. Did you miss yesterday's Chart of the Day? Click here to view it now. DC2 Publishing LLC 4260 NW 1st Avenue Suite # 55 Boca Raton, FL 33431 – 4264 Daily Guru Trades Copyright © 2023 Daily Guru Trades, All rights reserved. You are receiving this email as part of your subscription to Daily Guru Trades. If you have any questions, please contact us at support@dailygurutrades.com. Daily Guru Trades is a newsletter offered to the public on a subscription basis. While subscribers receive the benefit of Daily Guru Trades opinions, none of the information contained therein constitutes a recommendation from Daily Guru Trades that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Daily Guru Trades may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Daily Guru Trades' past results are not necessarily indicative of future performance. Employees of Daily Guru Trades are subject to certain restrictions in transacting for their own benefit. SPECIFICALLY, EMPLOYEES ARE NOT PERMITTED TO BUY OR SELL ANY SECURITY RECOMMENDED FOR THREE (3) TRADING DAYS FOLLOWING THE ISSUE OF A REPORT OR UPDATE. Daily Guru Trades' Newsletter contains Daily Guru Trades' own opinions, and none of the information contained therein constitutes a recommendation by Daily Guru Trades that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. Daily Guru Trades' past results are not necessarily indicative of future performance. DO NOT EMAIL Daily Guru Trades SEEKING PERSONALIZED INVESTMENT ADVICE, WHICH WE CANNOT PROVIDE. The Editor's personal investing goals and risk tolerance may be substantially different from those discussed in the Newsletter and/or circumstances may have changed by the expiration of the three day restricted period, the investment actions taken by the Editor in the accounts the Editor directly or indirectly owns may vary from (and may even be contrary to) the advice and recommendations in the Newsletter.Investing involves substantial risk. Neither the Editor, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from using the Newsletter. While past performance may be analyzed in the Newsletter, past performance should not be considered indicative of future performance. No subscriber should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing the prospectus and other public filings of the issuer. To the maximum extent permitted by law, the Editor, the publisher and their respective affiliates disclaim any and all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations in the Newsletter prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses. The Newsletter's commentary, analysis, opinions, advice and recommendations represent the personal and subjective views of the Editor and are subject to change at any time without notice.The information provided in the Newsletter is obtained from sources which the Editor believes to be reliable. However, the Editor has not independently verified or otherwise investigated all such information. Neither the Editor, the publisher, nor any of their respective affiliates guarantees the accuracy or completeness of any such information. The Newsletter is not a solicitation or offer to buy or sell any securities. Further, the Newsletter is in no way intended to be a solicitation for any services offered by Daily Guru Trades Neither the Editor, the publisher, nor any of their respective affiliates are responsible for any errors or omissions in the Newsletter. You are receiving this email because you are subscribed to Daily Guru Trades. If you no longer wish to receive these partner emails, please unsubscribe here.